SANGAMO THERAPEUTICS, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
SANGAMO THERAPEUTICS, INC. (SGMOQ) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $158.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-05-14
- SANGAMO THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $158.00K, a 82.52% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $924.00K, a 3.36% increase year-over-year.
- SANGAMO THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $909.00K, a 0.00% change year-over-year.
- SANGAMO THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-06-30 was $904.00K, a 32.08% decline year-over-year.
- SANGAMO THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $3.64M, a 14.41% decline from fiscal 2024.
- SANGAMO THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $4.25M, a 40.31% decline from fiscal 2023.
- SANGAMO THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $7.13M, a 15.70% decline from fiscal 2022.
- SANGAMO THERAPEUTICS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $8.45M, a 3.11% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $158.00K 10-Q · filed 2026-05-14 | $1.08M derived: sum of 2 quarters · filed 2026-05-14 | $1.99M derived: sum of 3 quarters · filed 2026-05-14 | $2.90M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $924.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.83M derived: sum of 2 quarters · filed 2026-03-30 | $2.74M derived: sum of 3 quarters · filed 2026-03-30 | $3.64M 10-K · filed 2026-03-30 |
| 2025-09-30 | $909.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.81M derived: sum of 2 quarters · filed 2025-11-06 | $2.72M 10-Q · filed 2025-11-06 | $3.61M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | $904.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.81M 10-Q · filed 2025-08-07 | $2.70M derived: sum of 3 quarters · filed 2026-05-14 | $3.61M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | $904.00K 10-Q · filed 2026-05-14 | $1.80M derived: sum of 2 quarters · filed 2026-05-14 | $2.71M derived: sum of 3 quarters · filed 2026-05-14 | $4.04M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $894.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.80M derived: sum of 2 quarters · filed 2026-03-30 | $3.13M derived: sum of 3 quarters · filed 2026-03-30 | $4.25M 10-K · filed 2026-03-30 |
| 2024-09-30 | $909.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.24M derived: sum of 2 quarters · filed 2025-11-06 | $3.36M 10-Q · filed 2025-11-06 | $4.54M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.45M 10-Q · filed 2025-08-07 | $3.63M derived: sum of 3 quarters · filed 2025-08-07 | $5.56M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.12M 10-Q · filed 2025-05-12 | $2.30M derived: sum of 2 quarters · filed 2025-05-12 | $4.23M derived: sum of 3 quarters · filed 2025-05-12 | $6.16M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $3.11M derived: sum of 2 quarters · filed 2025-03-17 | $5.04M derived: sum of 3 quarters · filed 2025-03-17 | $7.13M 10-K · filed 2025-03-17 |
| 2023-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.85M derived: sum of 2 quarters · filed 2024-11-12 | $5.95M 10-Q · filed 2024-11-12 | $8.04M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $4.02M 10-Q · filed 2024-08-06 | $6.12M derived: sum of 3 quarters · filed 2024-08-06 | |
| 2023-03-31 | $2.09M 10-Q · filed 2024-05-09 | $4.19M derived: sum of 2 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $8.45M 10-K · filed 2024-03-13 | ||
| 2022-09-30 | $6.36M 10-Q · filed 2023-11-01 | |||
| 2021-12-31 | $8.20M 10-K · filed 2024-03-13 |